Literature DB >> 28420724

A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis.

Caifeng Liu1,2, Yunjian Zhang1,3, Sharon Lim1, Kayoko Hosaka1, Yunlong Yang1,4, Tatiana Pavlova1, Twana Alkasalias1, Johan Hartman5, Lasse Jensen1,6, Xiaoming Xing7, Xinsheng Wang7, Yongtian Lu4, Guohui Nie8, Yihai Cao9,4,7.   

Abstract

Purpose: Cancer metastasis can occur at the early stage of tumor development when a primary tumor is at the microscopic size. In particular, the interaction of malignant cells with other cell types including cancer-associated fibroblasts (CAF) in promoting metastasis at the early stage of tumor development remains largely unknown. Here, we investigated the role of CAFs in facilitating the initial events of cancer metastasis when primary tumors were at microscopic sizes.Experimental Design: Multicolor-coded cancer cells and CAFs were coimplanted into the transparent zebrafish body and metastasis at a single-cell level was monitored in living animals. Healthy fibroblasts, tumor factor-educated fibroblasts, and CAFs isolated from various tumors were tested for their ability to facilitate metastasis.
Results: We showed that CAFs promoted cancer cell metastasis at the very early stage during primary tumor development. When a primary tumor was at the microscopic size consisting of a few hundred cells, CAFs were able to hijack cancer cells for dissemination from the primary site. Surprisingly, a majority of metastatic cancer cells remained in tight association with CAFs in the circulation. Furthermore, stimulation of non-metastasis-promoting normal fibroblasts with TGF-B, FGF-2, HGF, and PDGF-BB led to acquisition of their metastatic capacity.Conclusions: Cancer metastasis occurs at the very early stage of tumor formation consisting of only a few hundred cells. CAFs are the key cellular determinant for metastasis. Our findings provide novel mechanistic insights on CAFs in promoting cancer metastasis and targeting CAFs for cancer therapy should be aimed at the early stage during cancer development. Clin Cancer Res; 23(16); 4769-79. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 28420724     DOI: 10.1158/1078-0432.CCR-17-0101

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  36 in total

Review 1.  Adipocyte and lipid metabolism in cancer drug resistance.

Authors:  Yihai Cao
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

2.  Morphine alters the circulating proteolytic profile in mice: functional consequences on cellular migration and invasion.

Authors:  Nan Xie; Samira Khabbazi; Zeyad D Nassar; Kye Gregory; Tharindu Vithanage; Bela Anand-Apte; Peter J Cabot; David Sturgess; Paul N Shaw; Marie-Odile Parat
Journal:  FASEB J       Date:  2017-08-07       Impact factor: 5.191

3.  Novel concept of the smart NIR-light-controlled drug release of black phosphorus nanostructure for cancer therapy.

Authors:  Meng Qiu; Dou Wang; Weiyuan Liang; Liping Liu; Yin Zhang; Xing Chen; David Kipkemoi Sang; Chenyang Xing; Zhongjun Li; Biqin Dong; Feng Xing; Dianyuan Fan; Shiyun Bao; Han Zhang; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

4.  Zebrafish xenograft model for studying the function of lncRNA SNHG4 in the proliferation and migration of colorectal cancer.

Authors:  Jian Wang; Xiao-Yu Zhang; Dong-Yan Xu
Journal:  J Gastrointest Oncol       Date:  2022-02

5.  Rethinking carcinogenesis: The detached pericyte hypothesis.

Authors:  Stuart G Baker
Journal:  Med Hypotheses       Date:  2020-06-30       Impact factor: 1.538

6.  Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo.

Authors:  Xingkang He; Xin Yin; Jing Wu; Stina L Wickström; Yanhong Duo; Qiqiao Du; Shuhang Qin; Shuzhong Yao; Xu Jing; Kayoko Hosaka; Jieyu Wu; Lasse D Jensen; Andreas Lundqvist; Alexander I Salter; Lars Bräutigam; Wei Tao; Yuguo Chen; Rolf Kiessling; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-28       Impact factor: 11.205

7.  Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis.

Authors:  Patrik Andersson; Yunlong Yang; Kayoko Hosaka; Yin Zhang; Carina Fischer; Harald Braun; Shuzhen Liu; Guohua Yu; Shihai Liu; Rudi Beyaert; Mayland Chang; Qi Li; Yihai Cao
Journal:  JCI Insight       Date:  2018-10-18

8.  Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.

Authors:  Utsav Sharma; Kelsie Medina-Saenz; Philip C Miller; Benjamin Troness; Angela Spartz; Ana Sandoval-Leon; Deanna N Parke; Tiffany N Seagroves; Marc E Lippman; Dorraya El-Ashry
Journal:  Breast Cancer Res Treat       Date:  2021-07-03       Impact factor: 4.872

Review 9.  Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.

Authors:  Michael Yamakawa; Susan J Doh; Samuel M Santosa; Mario Montana; Ellen C Qin; Hyunjoon Kong; Kyu-Yeon Han; Charles Yu; Mark I Rosenblatt; Andrius Kazlauskas; Jin-Hong Chang; Dimitri T Azar
Journal:  Med Res Rev       Date:  2018-03-12       Impact factor: 12.944

Review 10.  Cancer models in preclinical research: A chronicle review of advancement in effective cancer research.

Authors:  Humna Sajjad; Saiqa Imtiaz; Tayyaba Noor; Yusra Hasan Siddiqui; Anila Sajjad; Muhammad Zia
Journal:  Animal Model Exp Med       Date:  2021-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.